Patents by Inventor Richard E. Randall

Richard E. Randall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Adjuvants
    Patent number: 11406704
    Abstract: The present disclosure provides novel adjuvants which may be used in combination with one or more antigens to augment, modulate or enhance a host immune response to the one or more antigens. The adjuvants are based on sialic acid binding molecules and may be combined with any type of antigen. The adjuvants may be formulated for mucosal and/or intranasal administration.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: August 9, 2022
    Assignee: PNEUMAGEN LIMITED
    Inventors: Helen Connaris, Garry Taylor, Richard E. Randall
  • NOVEL ADJUVANTS
    Publication number: 20190224311
    Abstract: The present disclosure provides novel adjuvants which may be used in combination with one or more antigens to augment, modulate or enhance a host immune response to the one or more antigens. The adjuvants are based on sialic acid binding molecules and may be combined with any type of antigen. The adjuvants may be formulated for mucosal and/or intranasal administration.
    Type: Application
    Filed: September 20, 2017
    Publication date: July 25, 2019
    Inventors: Helen Connaris, Garry Taylor, Richard E. Randall